CTRI/2016/01/006558已完成2 期
An Observational, Phase II study of efficacy of metronomic chemotherapy in patients with relapsed epithelial ovarian carcinoma with elucidation of its potential mechanisms of action by study of angiogenesis and apoptosis. - ECTOC
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i.Histologically or cytologically confirmed epithelial ovarian carcinoma.
- •ii.Patients who achieved complete remission with 1st-line treatment and at least partial response after 2nd-line chemotherapy.
- •iii.Patients who have clear disease progression after 2nd CR or PR
- •iv.ECOG performance status 0-2.
- •v.Adequate renal, hepatic and hematopoeitic functions.
- •vi.Baseline CA-125 value >= 40 U/ml, confirmed by repeat testing at baseline (to make it consistent with the definition of serological response by Rustin criteria).
- •vii.Patients who give informed consent to participate in the Study and are willing to comply with the follow-up schedule
排除标准
- •i.Any other chemotherapy in the 4 weeks prior to inclusion in this study.
- •ii.Participation in another research protocol at the same time.
- •iii.Patients with evidence of partial or complete intestinal obstruction, who will be unable to comply with an oral chemotherapy protocol.
研究者
相似试验
尚未招募
不适用
Observational study on the effectiveness of the medical device Beurer EM 50 Menstrual Relax in reducing menstrual pain associated with primary dysmenorrhoea (ReduPain)N94.4Primary dysmenorrhoeaDRKS00024411Institut Prof. Kurscheid58
招募中
不适用
The study evaluate the efficacy of intraoperative radiotherapy those who underwent neoadjuvant chemotherapy for pancreatic cancer.KCT0005113Yonsei University Health System, Gangnam Severance Hospital80
招募中
2 期
A phase II study to evaluate the effectiveness of S-1 + Cetuximab for patients with advanced/recurrent colon cancer who cannot undergo intensive therapyadvanced/recurrent colon cancer patients with RAS wild-type tumors who cannot undergo intensive therapyJPRN-UMIN000018484HO HOKKAIDO CANCER CENTER Division of Gastroenterology57
已完成
2 期
A phase II study to investigate the efficacy of neoadjuvant erlotinib in patients with clinical stage I/II non-small cell lung cancer (NSCLC)early stage lung cancernon-small cell lung cancer stage I/II10038666NL-OMON29708Antoni van Leeuwenhoek Ziekenhuis55
进行中（未招募）
1 期
Study to assess efficacy and safety of the medication named Idarubicin given orally every other day to patients with advanced tumor of the liver who progressed or are intoelrant to the medication Sorafenib and RegorafenibPatients with interemdiate-advanced stage hepatocarcinomaMedDRA version: 21.0Level: LLTClassification code 10024662Term: Liver cell carcinoma non-resectableSystem Organ Class: 100000004864EUCTR2017-003653-42-ITCENTRO DI RIFERIMENTO ONCOLOGICO47